ThetaPal ThetaPal

Manufacturing / In Vitro, In Vivo Diagnostic Substances

Lantheus Holdings, Inc.

LNTH

$100.54

-$0.25 (-0.25%)

Price as of Sep 18, 2026 23:51 UTC

6.1 B

Market Cap (Mid Cap)

Nov 04

Next Earnings

Technical Signals as of Sep 16
Bearish
1 of 7

Trend

  • Above 20-day average $100.76
  • Above 50-day average $100.90
  • Above 200-day average $85.30 · +17.9%
  • Moving averages stacked Not aligned

Momentum

  • Golden cross (50/200) —
  • Momentum cross (20/50) Down · 6d ago

Volume

  • Below-average volume 0.6x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Heat Map

Delta-risk grid for LNTH options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

0 buys 14 sells
Date Insider Title Type Shares Value Since Trade
May 14, 2026 Heino Mary Anne Tax_withholding 1,227 $118,614 +4.0%
May 14, 2026 Morrow Phuong Khanh Other 4,137 $0 +4.0%
May 14, 2026 Thrall James H Grant 4,137 $0 +4.0%
May 14, 2026 LENO SAM R Grant 4,137 $0 +4.0%
May 14, 2026 Morrow Phuong Khanh Grant 4,137 $0 +4.0%
May 14, 2026 Pruden Gary J Grant 4,137 $0 +4.0%
May 14, 2026 Baylor-Henry Minnie Grant 4,137 $0 +4.0%
May 14, 2026 Ber Gerard Grant 4,137 $0 +4.0%
May 14, 2026 EASTLAND JULIA MARIE Grant 4,137 $0 +4.0%
May 14, 2026 Maeusli Heinz Christoph Other 4,137 $0 +4.0%

Politician Trades in LNTH

Date Politician Party Type Amount Since Buy
Jan 28, 2025 Gil Cisneros D Purchase $1K-$15K +10.3%
Jan 13, 2025 Gil Cisneros D Purchase $1K-$15K +6.2%
Jan 08, 2025 Gil Cisneros D Purchase $1K-$15K +7.0%
Jan 07, 2025 Gil Cisneros D Purchase $1K-$15K +3.7%

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Aug 06, 2026 Q2 2026 $1.32
Aug 04, 2026 Q2 2026 $1.32
Jul 30, 2026 Q2 2026 $1.32
Mar 31, 2026 Q1 2026 $1.26 $1.46 +15.9% Beat
Dec 31, 2025 Q4 2025 $1.19 $1.67 +40.2% Beat
Sep 30, 2025 Q3 2025 $1.29 $1.27 -1.5% Miss
Jun 30, 2025 Q2 2025 $1.71 $1.57 -8.0% Miss

Track LNTH with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for LNTH and your entire portfolio.